© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Is it Possible to Increase the Recognition of Your Business Using 3D Modeling?
Innovation
14/08/2024Is it Possible to Increase the Recognition of Your Business Using 3D Modeling?

In today’s highly competitive business landscape, standing out and being recognizable are paramount for success. Companies are constantly searching for innovative ways to capture their audience’s attention and distinguish themselves from competitor

Read Full PostRead - Eye Icon
Why Data Analytics Is Crucial For Business Growth
News
20/06/2022Why Data Analytics Is Crucial For Business Growth

In today’s increasingly competitive business world, data is the new gold. The wide availability of data that businesses generate contains game-changing insights. These may bring relevant information about your customer's buying behavior, preferences, and the

Read Full PostRead - Eye Icon
The Beginner’s Guide to Starting a Consulting Business: Essential Steps and Tips
News
24/06/2024The Beginner’s Guide to Starting a Consulting Business: Essential Steps and Tips

Building your own business and becoming an entrepreneur presents a challenge. However, beginning a consulting business where you assist others in managing their company more effectively can pose an even bigger challenge. This is mainly because when you open a

Read Full PostRead - Eye Icon
Essential eCommerce Features for Major Growth
Strategy
06/11/2020Essential eCommerce Features for Major Growth

With the right strategies, you can give your eCommerce business the best chance of success regardless of the circumstances. A mixture of customer loyalty, building a modern eCommerce website and focusing on long-term marketing efforts has proven to work for ot

Read Full PostRead - Eye Icon
3 strategies to reduce risk when replatforming your website
Technology
07/09/20263 strategies to reduce risk when replatforming your website

Replatforming your website can put years of established performance at risk. Even if your new platform works exactly as intended, it could still disrupt the customer journeys and commercial performance your business relies on. That makes protecting what alread

Read Full PostRead - Eye Icon
How to build and manage credible partnerships and affiliations in business
Finance
21/02/2018How to build and manage credible partnerships and affiliations in business

The rapid rise of brands and companies partnering with experts and influencers to endorse products or services has been ever-increasing in our social media focused world.

Read Full PostRead - Eye Icon
CTC Media, Inc. Announces Receipt of Final Tranche of Purchase Price for Business Sale
Finance
12/02/2016CTC Media, Inc. Announces Receipt of Final Tranche of Purchase Price for Business Sale

CTC Media, Inc. announced today that it has received the final tranche of the purchase price for its sale of 75% of the outstanding participation interests in its subsidiary CTC Investments LLC to UTV-Management LLC.

Read Full PostRead - Eye Icon
Consumer Spending on Mobile Devices Set to Top £53 Billion a Year by 2024
Finance
14/04/2015Consumer Spending on Mobile Devices Set to Top £53 Billion a Year by 2024

Consumers are set to spend £53.6 billion a year using their smartphones and tablets by 2024, compared with the £9.7 billion spent today, according to new research by Barclays.

Read Full PostRead - Eye Icon
Lawrence Grant Chartered Accountants
Finance
03/06/2016Lawrence Grant Chartered Accountants

Lawrence Grant Chartered Accountants has been providing accountancy services and tax advice to 100’s of individuals, sole traders, corporate businesses and multi-national clients across Middlesex and the Greater London area since 1969.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow